StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IMUX

Immunic, Inc.

IMUX Nasdaq Pharmaceutical Preparations EDGAR ↗
$14.10
+0.11 +0.79%

Key statistics

from XBRL data in SEC filings
Market cap
$192M
Revenue (TTM)
Net income (TTM)
-$104M
EPS (TTM)
$0.81
P/E ratio
17.4
Dividend yield
Free cash flow
-$86.0M
Cash
$187M
Total assets
$190M
Gross margin
52-week range
$5.06 – $15.84

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 14, 2026 8-K Director or officer change Jul 6, 2026 8-K Director or officer change; Shareholder vote results Jun 29, 2026 8-K Regulation FD disclosure May 28, 2026 8-K Director or officer change; Regulation FD disclosure May 27, 2026 8-K Director or officer change; Regulation FD disclosure May 19, 2026 8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Director or officer change; Regulation FD disclosure Apr 28, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Apr 23, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 22, 2026 8-K Shareholder vote results; Other events Apr 14, 2026 8-K Director or officer change Apr 10, 2026 8-K Other events Apr 1, 2026 8-K Director or officer change; Regulation FD disclosure Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Feb 13, 2026 8-K Delisting notice or listing-rule failure Jan 6, 2026 8-K Director or officer change Jan 5, 2026 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Other events Sep 25, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Other events Aug 7, 2025 8-K Director or officer change Jul 11, 2025 8-K Delisting notice or listing-rule failure Jun 27, 2025 8-K Director or officer change; Shareholder vote results Jun 4, 2025 8-K Entered a material agreement; Regulation FD disclosure May 30, 2025 8-K Other events May 28, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Other events Apr 30, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Other events Feb 20, 2025 8-K Other events Jan 13, 2025 8-K Director or officer change Dec 18, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Other events Nov 7, 2024 8-K Other events Oct 22, 2024